Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Natco Pharma Ltd. Board/Management Information 2026

Jun 30, 2026

62741_rns_2026-06-30_518ec4c3-4215-4928-a686-b58619f8463f.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

NATCO

Natco Pharma Limited

Regd. Off.: 'NATCO HOUSE', Road No. 2, Banjara Hills, Hyderabad - 500034.

Telangana, INDIA. Tel: +91 40 23547532, Fax: +91 40 23548243

CIN: L24230TG1981PLC003201, www.natcopharma.co.in

30th June, 2026

Corporate Relationship Department
M/s. BSE Limited
Dalal Street, Fort
Mumbai 400001

The Manager - Listing
M/s. National Stock Exchange of India Ltd
"Exchange Plaza", Bandra – Kurla Complex
Bandra (E) Mumbai 400051

Scrip Code: 524816
Scrip Code: NATCOPHARM

Dear Sir/Madam,

Sub:- Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

With reference to the above cited subject, we would like to inform you that in accordance with the provisions of Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Mr. Nadella Malleswara Rao, Vice President - Operations, Pharma Division – Kothur of the Company has superannuated today i.e., with effect from the closure of business hours on 30th June, 2026.

The details as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11th November, 2024 and SEBI Master Circular No.HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 updated on January 30, 2026 are as under:

Sl. No. Particulars
1 Name Nadella Malleswara Rao
2 Reason for Change in Senior Management Superannuation as Vice President - Operations, Pharma Division – Kothur of the Company
3 Date of appointment/re-appointment/cessation (as applicable) & term of appointment/re-appointment With effect from the closure of business hours on 30th June, 2026, Mr. Nadella Malleswara Rao has superannuated and shall cease to be Vice President – Operations, Pharma Division – Kothur of the Company
4 Brief profile Not Applicable
5 Disclosure of relationship between Directors Not Applicable

This is for your information and records.

Thanking you,

Yours faithfully,

For NATCO Pharma Limited

VEMAT
KAMCH
LINROR

Ch. Venkat Ramesh
Company Secretary &
Compliance Officer